Prevalence of Late-Onset Hypogonadism in Men with Localized and Metastatic Renal Cell Carcinoma

Publisher： Karger

E-ISSN： 1423-0399|98|2|191-197

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.98, Iss.2, 2016-10, pp. : 191-197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Effect of Testosterone and Fenofibrate, Administered Alone or in Combination, on Cardiometabolic Risk Factors in Men with Late‐Onset Hypogonadism and Atherogenic Dyslipidemia

By  

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol. 33, Iss. 5, 2015-10 ,pp. : 270-274

John Wiley & Sons Inc

Access to resources Recommend Favorite

Can testosterone level be a good predictor of late‐onset hypogonadism?

By  

ANDROLOGIA (ELECTRONIC), Vol. 47, Iss. 4, 2015-05 ,pp. : 433-437

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ramucirumab in metastatic renal cell carcinoma: The beginning or the end?

By  

CANCER, Vol. 120, Iss. 11, 2014-06 ,pp. : 1604-1607

John Wiley & Sons Inc

Access to resources Recommend Favorite

Urologic Approaches to Metastatic Renal Cell Carcinoma

By  

Oncology Research and Treatment, Vol. 24, Iss. 2, 2001-05 ,pp. : 122-126

Karger

Access to resources Recommend Favorite

Metastatectomy prior to Immunochemotherapy for Metastatic Renal Cell Carcinoma

By  

Urologia Internationalis, Vol. 76, Iss. 3, 2006-04 ,pp. : 256-263

Karger

Access to resources Recommend Favorite